167 related articles for article (PubMed ID: 11750922)
21. Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats.
Pan YP; Liu C; Liu MF; Wang Y; Bian K; Xue Y; Chen L
Neuropeptides; 2020 Apr; 80():102019. PubMed ID: 31980205
[TBL] [Abstract][Full Text] [Related]
22. Hypocretin-1 causes G protein activation and increases ACh release in rat pons.
Bernard R; Lydic R; Baghdoyan HA
Eur J Neurosci; 2003 Oct; 18(7):1775-85. PubMed ID: 14622212
[TBL] [Abstract][Full Text] [Related]
23. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors.
Palus K; Chrobok L; Lewandowski MH
Neuroscience; 2015 Aug; 300():370-80. PubMed ID: 26022361
[TBL] [Abstract][Full Text] [Related]
24. The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B.
Sheng Q; Xue Y; Wang Y; Chen AQ; Liu C; Liu YH; Chu HY; Chen L
Neuroscience; 2018 Jan; 369():97-108. PubMed ID: 29138106
[TBL] [Abstract][Full Text] [Related]
25. Effects of orexin (hypocretin) on GIRK channels.
Hoang QV; Bajic D; Yanagisawa M; Nakajima S; Nakajima Y
J Neurophysiol; 2003 Aug; 90(2):693-702. PubMed ID: 12702704
[TBL] [Abstract][Full Text] [Related]
26. Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells.
Cataldi NI; Lux-Lantos VA; Libertun C
Regul Pept; 2012 Oct; 178(1-3):56-63. PubMed ID: 22749989
[TBL] [Abstract][Full Text] [Related]
27. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline).
Brown RE; Sergeeva OA; Eriksson KS; Haas HL
J Neurosci; 2002 Oct; 22(20):8850-9. PubMed ID: 12388591
[TBL] [Abstract][Full Text] [Related]
28. Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents.
Gompf H; Chen J; Sun Y; Yanagisawa M; Aston-Jones G; Kelz MB
Anesthesiology; 2009 Nov; 111(5):1001-9. PubMed ID: 19809293
[TBL] [Abstract][Full Text] [Related]
29. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
Hooshmand B; Azizi H; Javan M; Semnanian S
Neurosci Lett; 2017 Jan; 636():276-281. PubMed ID: 27816550
[TBL] [Abstract][Full Text] [Related]
30. Orexin A activates locus coeruleus cell firing and increases arousal in the rat.
Hagan JJ; Leslie RA; Patel S; Evans ML; Wattam TA; Holmes S; Benham CD; Taylor SG; Routledge C; Hemmati P; Munton RP; Ashmeade TE; Shah AS; Hatcher JP; Hatcher PD; Jones DN; Smith MI; Piper DC; Hunter AJ; Porter RA; Upton N
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10911-6. PubMed ID: 10485925
[TBL] [Abstract][Full Text] [Related]
31. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.
Xue Y; Yang YT; Liu HY; Chen WF; Chen AQ; Sheng Q; Chen XY; Wang Y; Chen H; Liu HX; Pang YY; Chen L
Eur J Neurosci; 2016 Sep; 44(5):2247-57. PubMed ID: 27336845
[TBL] [Abstract][Full Text] [Related]
32. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus.
Sears RM; Fink AE; Wigestrand MB; Farb CR; de Lecea L; Ledoux JE
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20260-5. PubMed ID: 24277819
[TBL] [Abstract][Full Text] [Related]
33. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus.
Walling SG; Nutt DJ; Lalies MD; Harley CW
J Neurosci; 2004 Aug; 24(34):7421-6. PubMed ID: 15329388
[TBL] [Abstract][Full Text] [Related]
34. Orexin affects dorsal root ganglion neurons: a mechanism for regulating the spinal nociceptive processing.
Yan JA; Ge L; Huang W; Song B; Chen XW; Yu ZP
Physiol Res; 2008; 57(5):797-800. PubMed ID: 18973425
[TBL] [Abstract][Full Text] [Related]
35. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats.
Jia X; Yan J; Xia J; Xiong J; Wang T; Chen Y; Qi A; Yang N; Fan S; Ye J; Hu Z
Neuropharmacology; 2012 Feb; 62(2):775-83. PubMed ID: 21924278
[TBL] [Abstract][Full Text] [Related]
36. Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia.
Dong HL; Fukuda S; Murata E; Zhu Z; Higuchi T
Anesthesiology; 2006 May; 104(5):1023-32. PubMed ID: 16645455
[TBL] [Abstract][Full Text] [Related]
37. Orexin facilitates GABAergic IPSCs via postsynaptic OX
Usui M; Kaneko K; Oi Y; Kobayashi M
Neuropharmacology; 2019 May; 149():97-112. PubMed ID: 30763655
[TBL] [Abstract][Full Text] [Related]
38. Orexin excites rat inferior vestibular nuclear neurons via co-activation of OX1 and OX 2 receptors.
Yu L; Zhang XY; Chen ZP; Zhuang QX; Zhu JN; Wang JJ
J Neural Transm (Vienna); 2015 Jun; 122(6):747-55. PubMed ID: 25371350
[TBL] [Abstract][Full Text] [Related]
39. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
40. OX1 orexin/hypocretin receptor activation of phospholipase D.
Jäntti MH; Putula J; Somerharju P; Frohman MA; Kukkonen JP
Br J Pharmacol; 2012 Feb; 165(4b):1109-23. PubMed ID: 21718304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
